质子-光子联合治疗:无旋转机架质子治疗的新思路
本研究探讨一种无旋转机架质子治疗室设计,由标准直线加速器、可移动治疗床和水平笔束扫描质子束线组成,通过同时优化IMRT与IMPT的累积物理剂量实现质子-光子联合治疗。在3例头颈癌病例中,联合方案利用光子改善剂量适形性、质子降低正常组织积分剂量,在危及生活质量的OAR上优于单模态IMRT和固定束线IMPT计划,并保留了纯IMPT计划对健康组织积分剂量的大部分降低。
要点
- 无旋转机架质子治疗室由标准直线加速器、可移动治疗床和水平笔束扫描质子束线组成。
- 质子-光子联合治疗通过同时优化IMRT与IMPT计划的累积物理剂量实现。
- 在3例头颈癌中,联合方案在危及生活质量的OAR上优于单模态IMRT和固定束线IMPT计划。
核心结论
- 质子-光子联合治疗可能为无旋转机架质子治疗提供新方案,最佳组合可改善IMRT计划并降低副作用风险,同时使更多患者获得质子治疗。
研究设计与样本
- 治疗室由标准直线加速器(用于IMRT)、可移动治疗床(卧位治疗)和配备笔束扫描的水平质子束线组成。
- 因质子束限于冠状面,许多肿瘤部位的治疗计划可能欠佳,但通过联合质子与光子可实现高质量计划。
- 治疗计划基于IMRT与IMPT计划的累积物理剂量进行同时优化,并在3例头颈癌病例中展示该概念。
主要发现
- 最佳组合利用光子改善剂量适形性,同时质子降低正常组织的积分剂量。
- 联合治疗在危及生活质量的OAR上优于单模态IMRT和固定束线IMPT计划,并保留纯IMPT计划对健康组织积分剂量的大部分降低。
- 与单模态IMRT计划相比,多模态治疗可达到的较低剂量降低了副作用风险。
临床怎么用
- 在无旋转机架质子治疗室中,可考虑同时优化IMRT与IMPT计划,利用光子改善适形性、质子降低正常组织积分剂量。
- 该联合策略可能使质子治疗在常规屏蔽室内实施,从而惠及更多患者。
局限性
- 质子束限于冠状面,可能使许多肿瘤部位的治疗计划欠佳。
- 概念仅在3例头颈癌病例中展示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although the number of proton therapy centres is growing worldwide, proton therapy is still a limited resource. The primary reasons are gantry size and cost. Therefore, we investigate the potential of a new design for proton therapy, which may facilitate proton treatments in conventional bunkers and allow the widespread use of protons. MATERIALS AND METHODS: The treatment room consists of a standard Linac for IMRT, a motorized couch for treatments in lying position, and a horizontal proton beamline equipped with pencil beam scanning. As proton beams are limited to a coronal plane, treatment plans may be suboptimal for many tumour sites. However, high-quality plans may be realized by combining protons and photons. Treatment planning is performed by simultaneously optimizing IMRT and IMPT plans based on their cumulative physical dose. We demonstrate this concept for three head&neck cancer cases. RESULTS: Optimal combinations use photons to improve dose conformity while protons reduce the integral dose to normal tissues. In fact, combined treatments improve on single-modality IMRT and fixed beamline IMPT plans for quality-of-life-limiting OARs and retain most of the integral dose reduction in the healthy tissues of the pure IMPT plans. The lower doses that can be obtained with multi-modality treatments reduce the risk for side effects compared to single-modality IMRT plans. CONCLUSION: Combined proton-photon treatments may play a role in developing a new solution for proton therapy without a gantry. Optimal combinations improve on IMRT plans and reduce the risk of side effects while making protons available to more patients.
引用
- Fabiano S, Balermpas P, Guckenberger M, et al. Combined proton-photon treatments - A new approach to proton therapy without a gantry. Radiother Oncol. 2020. PMID: 31923713. doi:10.1016/j.radonc.2019.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。